Outpatient management of febrile neutropenia: is it safe yet?
Johnson
Tami N
TN
Department of Pharmacy Clinical Programs, The University of Texas M. D. Anderson Cancer Center, Houston 77030-4009, USA. tnjohnso@mdanderson.org
DeJesus
Yvette A
YA
McMahon
Leslie
L
Rolston
Kenneth V I
KV
Row
Margaret B
MB
D000553:Ambulatory Care; D000970:Antineoplastic Agents / Q000009:adverse effects; D005334:Fever / Q000150:complications; D006801:Humans; D009503:Neutropenia / Q000150:complications / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*
D000970:Antineoplastic Agents